© 2023 FinThrive, Inc. and its affiliates and subsidiaries (collectively, “FinThrive")" - All Rights Reserved
Version: 2023.11.27.2 ClearIQ - Patent Pending
Outpatient Evaluation - Patent Pending
FinThrive does not provide medical advice, diagnosis, or treatment advice. The information provided is based on historical medical information obtained from the Provider. Providers are responsible for determining appropriate diagnosis/treatment options.
* HFMA staff and volunteers determined that this product has met specific criteria developed under the HFMA Peer Review Process. HFMA does not endorse or guaranty the use of this product.
CPT only © 2023 American Medical Association. All rights reserved. CPT is a registered Trademark of the American Medical Association.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the AMA is not recommending their use.
The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
Site ID: 414
azrvpciqweb04 zz/Transunion/Direct (CLAIMS)
Auth Ticket Expires:
This product includes CPT® and/or CPT® Assistant and/or CPT® Changes, which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable, which were developed exclusively at private expense by the American Medical Association, 515 North State Street, Chicago, Illinois, 60654. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2) (November 1995) and/or subject to the restrictions of DFARS 227.7202-1(a) (June 1995) and DFARS 227.7202-3(a) (June 1995), as applicable, for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (December 2007) and/or subject to the restricted rights provisions of FAR 52.227-14 (December 2007) and FAR 52.227-19 (December 2007), as applicable, and any applicable agency FAR Supplements, for non-Department of Defense Federal procurements.
Applicable FARS/DFARS Restrictions Apply to Government Use